[What are the new French recommendations for the treatment of postmenopausal osteoporosis?].

Rev Med Interne

Pôle de gérontologie du CHU de Montpellier, service de médecine Interne-Gériatrie, centre Antonin Balmes, université de Montpellier, 39, avenue Charles-Flahaut, 34295 Montpellier cedex 5, France. Electronic address:

Published: May 2019

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.revmed.2018.05.008DOI Listing

Publication Analysis

Top Keywords

[what french
4
french recommendations
4
recommendations treatment
4
treatment postmenopausal
4
postmenopausal osteoporosis?]
4
[what
1
recommendations
1
treatment
1
postmenopausal
1
osteoporosis?]
1

Similar Publications

Purpose: Establishing an accurate prognosis remains challenging in older patients with cancer because of the population's heterogeneity and the current predictive models' reduced ability to capture the complex interactions between oncologic and geriatric predictors. We aim to develop and externally validate a new predictive score (the Geriatric Cancer Scoring System [GCSS]) to refine individualized prognosis for older patients with cancer during the first year after a geriatric assessment (GA).

Materials And Methods: Data were collected from two French prospective multicenter cohorts of patients with cancer 70 years and older, referred for GA: ELCAPA (training set January 2007-March 2016) and ONCODAGE (validation set August 2008-March 2010).

View Article and Find Full Text PDF

Healthcare resource utilization and costs in immunodeficient patients receiving subcutaneous Ig: Real-world evidence from France.

PLoS One

January 2025

French National Reference Center for Primary Immunodeficiencies (CEREDIH) and Pediatric Immunology, Hematology and Rheumatology Unit, Necker Enfants Malades University Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.

Background: Subcutaneous immunoglobulin (SCIg) replacement therapy is indicated for patients with hypogammaglobulinemia caused by primary (PID) and secondary immunodeficiencies (SID).

Objective: To compare healthcare resource utilization (HCRU) and related direct medical costs of patients in France treated with weekly conventional SCIg (cSCIg) vs monthly hyaluronidase-facilitated SCIg (fSCIg).

Methods: This retrospective study of Ig-naïve patients with PID or SID newly receiving a SCIg between 2016 and 2018, extracted from the French National Healthcare reimbursement database (SNDS), analyzed the SCIg-related HCRU and reimbursed costs generated from in-hospital (hospitalizations and SCIg doses) or at-home (nurse visits [NV] and pump provider visits [PPV], drug doses) SCIg administration.

View Article and Find Full Text PDF

Introduction: A leadless pacemaker (LLPM) was recommended for a patient with intermittent complete heart block and near-syncope.

Methods And Results: Delivery of LLPM is through a large sheath that has limited deflection and steerability. This report describes the successful deployment of a ventricular LLPM in a patient with prior surgical correction of AV septal defect with subsequent significant right atrial enlargement.

View Article and Find Full Text PDF

Semiconducting Overoxidized Polypyrrole Nano-Particles for Photocatalytic Water Splitting.

Small

January 2025

UMR 8182, CNRS, Institut de Chimie Moléculaires et des Matériaux d'Orsay, Université Paris-Saclay, Orsay, 91405, France.

Capturing sunlight to fuel the water splitting reaction (WSR) into O and H is the leitmotif of the research around artificial photosynthesis. Organic semiconductors have now joined the quorum of materials currently dominated by inorganic oxides, where for both families of compounds the bandgaps and energies can be adjusted synthetically to perform the Water Splitting Reaction. However, elaborated and tedious synthetic pathways are necessary to optimize the photophysical properties of organic semiconductors.

View Article and Find Full Text PDF

Objective: The Psychosocial Assessment Tool (PAT) is a brief caregiver report, family-centered, psychosocial risk screening tool widely used in pediatrics and available in many languages. Although French is an official language of Canada, a French-Canadian version of the PAT has not yet been validated, which impedes access to this tool for family psychosocial screening. This study aimed to translate, adapt as necessary, and validate the French-Canadian version of the PAT.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!